title: Testosterone deficiency as a risk factor for cardiovascular disease.
abstract: Testosterone deficiency (TD) has become a frequently diagnosed condition in our current society with an obesity epidemic. Men diagnosed with TD often have co-morbidities including metabolic syndrome. Challenging aspects in diagnosing and treating patients with TD include intra-individual variation of symptoms combined with lack of its correlation with serum levels of testosterone. Apart from sexual aspects including libido and erectile function, replacement therapy with testosterone might have beneficial metabolic effects, whereas untreated TD might increase cardiometabolic risk and disease. In this article, we review the cardiovascular and metabolic risks associated with TD, as well as risks and benefits of testosterone replacement therapy. We also provide insights into potential mechanisms of the association between cardiometabolic risks with TD (treated and untreated) and propose an individual treatment algorithm.
authors.affiliation: Division of General Internal Medicine, University of Mississippi Medical Center, Jackson, USA.
authors.forename: M I
authors.initials: MI
authors.lastname: Ullah
authors.forename: T
authors.initials: T
authors.lastname: Washington
authors.forename: M
authors.initials: M
authors.lastname: Kazi
authors.forename: S
authors.initials: S
authors.lastname: Tamanna
authors.forename: C A
authors.initials: CA
authors.lastname: Koch
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D012307:Risk Factors; D013739:Testosterone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use
chemical_list: D013739:Testosterone